KCNH2 and cardiac arrhythmia: Co-administration with other pro-arrhythmic drugs, including azithromycin (hERG IC50 = 219 μM [59]), may lower the safe exposure level of HCQ (noting that reported cases of azithromycin-induced arrhythmia [49] have been attributed to intra-cellular Na+ loading [59]).